Gordana Tovilovic-Kovacevic

Dr. Gordana Tovilovic-Kovacevic

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in European Journal of Pharmacology
Verified
Journal Article
Closed access
KJKristina Janjetovic
Kristina Janjetovic
LVLjubica Vucicevic
Ljubica Vucicevic
MMMaja Misirkic Marjanovic
Maja Misirkic Marjanovic
UVUrosh Vilimanovich
Urosh Vilimanovich
GTGordana Tovilovic-Kovacevic
Gordana Tovilovic-Kovacevic
LHLjubica Harhaji-Trajkovic
Ljubica Harhaji-Trajkovic

27 April 2012 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
LHLjubica Harhaji-Trajkovic
Ljubica Harhaji-Trajkovic
KAKatarina Arsikin
Katarina Arsikin
TKTamara Kravic-Stevovic
Tamara Kravic-Stevovic
SPSasa Petricevic
Sasa Petricevic
GTGordana Tovilovic-Kovacevic
Gordana Tovilovic-Kovacevic
VTVladimir Trajkovic
Vladimir Trajkovic

1 January 2012 in Pharmacological Research
Verified
Journal Article
Closed access
MMMaja Misirkic Marjanovic
Maja Misirkic Marjanovic
KJKristina Janjetovic
Kristina Janjetovic
LVLjubica Vucicevic
Ljubica Vucicevic
GTGordana Tovilovic-Kovacevic
Gordana Tovilovic-Kovacevic
Biljana RisticBiljana Ristic
Biljana Ristic
VTVladimir Trajkovic
Vladimir Trajkovic

1 November 2012 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
KAKatarina Arsikin
Katarina Arsikin
TKTamara Kravic-Stevovic
Tamara Kravic-Stevovic
MJMaja Jovanovic
Maja Jovanovic
Biljana RisticBiljana Ristic
Biljana Ristic
GTGordana Tovilovic-Kovacevic
Gordana Tovilovic-Kovacevic
LHLjubica Harhaji-Trajkovic
Ljubica Harhaji-Trajkovic

22 December 2013 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
MPMarija Pergal
Marija Pergal
JNJelena Nestorov
Jelena Nestorov
GTGordana Tovilovic-Kovacevic
Gordana Tovilovic-Kovacevic
SOSanja Ostojic
Sanja Ostojic
Dejan GođevacDejan Gođevac
Dejan Gođevac
JDJasna Djonlagić
Jasna Djonlagić

1 June 2016 in Food & Function
Verified
Journal Article
Closed access
PDF file
MTMirko Tomic
Mirko Tomic
ĐIĐurđica Ignjatović
Đurđica Ignjatović
GTGordana Tovilovic-Kovacevic
Gordana Tovilovic-Kovacevic
DKDijana Krstić-Milošević
Dijana Krstić-Milošević
SRSlavica Ranković
Slavica Ranković
MGMarija Glibetić
Marija Glibetić
The treatment of mood and anxiety disorders by nutraceuticals is gaining growing awareness. Berries of Aronia melanocarpa (Black chokeberry) and their extracts, exceptionally abundant in diverse phenolic compounds, have become famous for the highest in vitro antioxidant activity among fruits and notable health benefits (e.g. anti-diabetic, anti-inflammatory, cardioprotective). This study was designed to investigate the behavioral effects of month-long unlimited consumption of Aronia master juice (AJ) and/or juice reconstruct without polyphenols (RJ), in young male rats. AJ was initially evaluated for its content of phenolic compounds by spectrophotometric assays and HPLC-DAD. Rats that were supplied with three various water concentrations of AJ and RJ, respectively: 20% + 0% (ARO group), 5% + 15% (RAJ) and 0 + 20% (PLC), were compared with those which consumed only water (CTL). Daily drinking of AJ solution was significantly elevated from the second or third week onward, which was most expressed in the ARO group. Only this group displayed behavioral variations, manifested by certain hyperactivity in open field tests and prominent reductions of anxiety-like behaviors in the elevated plus maze. The ARO rats also expressed an alleviation of depression-like behavior in forced swimming tests. These findings demonstrate the beneficial behavioral effects of the one-month-long free drinking of phenolic-rich AJ in rats (>20 ml per kg b. mass daily) that may be recognized as stimulating, anxiolytic-like and antidepressant-like. The in vitro assays suggested that MAO-A/MAO-B inhibitions by the phenolic compounds of AJ might be the possible in vivo mechanisms for such behavioral actions.